Oppenheimer Asset Management’s Avanos Medical AVNS Stock Holding History

Oppenheimer Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,038	Closed	-$277K	–	1165
2020 Q4	$277K	Sell	6,038 -3,508	-37%	-$146K	﹤0.01%	1005
2020 Q3	$317K	Sell	9,546 -4,670	-33%	-$149K	0.01%	916
2020 Q2	$418K	Sell	14,216 -12,591	-47%	-$365K	0.01%	833
2020 Q1	$722K	Buy	26,807 +16,321	+156%	+$487K	0.02%	639
2019 Q4	$353K	Buy	+10,486	New	+$380K	0.01%	923
2018 Q1	–	Sell	-17,429	Closed	-$785K	–	1122
2017 Q4	$785K	Hold	17,429	–	–	0.02%	670
2017 Q3	$785K	Buy	17,429 +2,652	+18%	+$113K	0.02%	673
2017 Q2	$580K	Sell	14,777 -29	-0.2%	-$1.1K	0.02%	737
2017 Q1	$564K	Buy	+14,806	New	+$577K	0.02%	752

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer Asset Management's AVNS Position: Q1 2021 in Review

Oppenheimer Asset Management sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 6,038 shares — an estimated $277K sold.

Oppenheimer Asset Management first reported a position in AVNS in Q1 2017 and held it in 9 quarters. The position peaked at $785K in Q4 2017. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

Oppenheimer Asset Management reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
Oppenheimer Asset Management sold 6,038 Avanos Medical shares in Q1 2021, an estimated $277K.
Oppenheimer Asset Management first reported a position in Avanos Medical in Q1 2017 and held it in 9 quarters.
Oppenheimer Asset Management's Avanos Medical position peaked at $785K in Q4 2017.
291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Oppenheimer Asset Management's 13F filing for Q1 2021, filed 17 May 2021.